Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Focus On The Prevention Of Heart Disease And Stroke During The Clinton Global Initiative

20.09.2006
The World Heart Federation, a nongovernmental organisation dedicated to the prevention and control of heart disease and stroke, with a focus on low- and middle-income countries, is taking an active part in the second annual meeting of the Clinton Global Initiative (CGI).

The event, taking place in New York between 20 - 22 September will bring together over 1,000 global leaders from business, politics, academia, science, religion, and non-governmental organizations, including numerous Heads of State and CEOs from major international corporations. CGI is a forum for participants to discuss and develop workable solutions to some of the world's most pressing challenges, including the prevention of heart disease and stroke which claims 17.5 million lives a year, 80% of these in low and middle income countries.

The World Heart Federation will announce two major new commitments for which partial funding has already been committed but needs to be met by pledges of additional support by the global leaders during or after the CGI.

Prevention of Rheumatic Fever / Rheumatic Heart Disease in Africa

The World Heart Federation will set up four demonstration projects, one in each of Egypt, Ethiopia, Ghana and South Africa, that will grow into sustainable, long-term, government-run national rheumatic heart disease-control programmes. The projects will raise awareness through public and professional education, establish surveillance systems, advocate improving health services, and promote effective prevention measures.

Rheumatic fever (RF) can develop after an infection by the group A streptococcus bacterium. The resulting inflammatory illness can damage heart valves; this is called rheumatic heart disease (RHD) and can lead to disability or death. RF and RHD affects 15.6 million people worldwide, including 2.4 million children, and is the most common cardiovascular disease of children and young adults. There are nearly half a million new cases every year, 300,000 of them in Africa. Hundreds of thousands of people are disabled by RHD and some 350,000 die from it each year. 233,000 of those deaths are in Africa.

The tragedy is that almost all of these deaths are easily preventable using regular injection of penicillin. Despite the wide availability and the proven effectiveness of penicillin for the prevention of RF and RHD, developing countries continue to face unacceptably high rates of RF and RHD, making RHD the most common cardiovascular disease affecting children and young adults in the world .

“Our aim is to significantly reduce mortality, morbidity and disability from rheumatic fever/rheumatic heart disease among African children and young adults,” said Dr Jonathan Carapetis, chairman of the World Heart Federation’s Scientific Council on Rheumatic Fever and Rheumatic Heart Disease. “Rheumatic heart disease shortens people’s lives and aggravates human misery. We will train health workers in how to identify and treat patients, and public health officials in how to establish and maintain prevention programmes. But this is not enough. We will also advocate for guaranteed supplies of high-quality antibiotics and for rheumatic heart disease to be recognized as an international clinical, public health and political priority.”

The World Heart Federation is presently leading the global effort in RHD control. Its RHD control project in the South Pacific, which began in 2005, has a regional training programme and demonstration projects in Fiji and Samoa. So far, the project has screened 3,000 children and its first regional training workshop will be held this October. The WHO supports the programme and is co-sponsoring the workshop. Tools developed and experiences gained in the Pacific are being made available to the world through the World Heart Federation website, and will be adapted for the project in Africa.

Development, Production and Delivery of the Polypill

The World Heart Federation also intends to advocate for the development, production and delivery of the polypill for the secondary prevention of cardiovascular disease in post myocardial infarction patients by 2009/10. The initiative conducted in partnership with CNIC, the Spanish National Centre for Cardiovascular Research.

The aim is to save the lives of those severely affected by cardiovascular disease by successfully completing the development of a polypill or fixed dose combination of ace inhibitor, statin and aspirin therapies.

The aim is also to build knowledge and commitment among practicing physicians particularly in low- and middle-income countries to facilitate distribution as of 2010. Pilot countries are being identified but will probably include Spain and China.

The World Heart Federation’s primary contribution would be in the area of advocacy and education. The World Heart Federation would advocate for the polypill with the relevant authorities including the FDA and EMEA, and through its national member societies, journals and congresses encourage its inclusion in national guidelines and use by cardiologists in post myocardial infarction patients.

With chronic diseases including cardiovascular disease and diabetes accounting for 60% of global mortality, and 80% of that burden in low and middle-income countries, it is time to advance the prevention agenda as well as patient care. It is proven that appropriate stand-alone medications ranging from statins to aspirin have had very beneficial effects on premature mortality in Western populations. Many of these medications are now off patent and as such are available at lower generic prices. However, the complexity of three or more medications would strain developing country health systems both financially and logistically. Patient compliance would be another complicating factor.

A polypill is estimated to cost one-fifth of currently available therapies and save the lives of post-myocardial infarction patients as well as high risk individuals in low- and middle-income countries as well as low income patients in more developed economies who would otherwise have limited treatment options. The production of the polypill has been recommended in recent reports by the World Health Organization.

Michelle Roverelli | alfa
Further information:
http://www.cwnewsroom.ch

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>